Skip to main content
SpringerLink
Log in

Add-on LTRA more cost effective in older asthma patients

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2010 US dollars

  2. cardiovascular

Reference

  • Altawalbeh SM, et al. Cost-Utility Analysis of Long-Acting Beta Agonists versus Leukotriene Receptor Antagonists in Older Adults with Persistent Asthma Receiving Concomitant Inhaled Corticosteroid Therapy. Value in Health 19: 537-43, No. 5, Jul 2016. Available from: URL: http://doi.org/10.1016/j.jval.2016.02.004

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Add-on LTRA more cost effective in older asthma patients. PharmacoEcon Outcomes News 761, 7 (2016). https://doi.org/10.1007/s40274-016-3347-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3347-z

Search

Navigation